ArticleAntibiotics (Basel, Switzerland)2023

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections.

Pasquale Maria Berrino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.